RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Heidelberg biochemists and structural biologists from Shanghai unravel the roles of two key regulatory factors in mRNA ...

From stock decline to Hold rating, explore their growth strategy, client focus, and potential gains. Click for my MRVI update ...

Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA ...

Some, according to KFF Health News, are also pressing regulators to revoke federal approval for mRNA-based COVID shots, which President Donald Trump has touted as a key first-term achievement. Novavax ...

Scientists found that pseudouridine helps small RNAs pass on traits and avoid immune detection, offering clues for future RNA ...

Kim V. Narry, director of the Center for RNA Research of the Institute for Basic Science and chair professor at the ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, ...

We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...